The present invention relates in general to devices and methods for determining the amount of compression over a wound to create hemostasis and, in particular, to devices and methods for achieving hemostasis of a blood vessel immediately after a vascular catheterization procedure.
Many medical procedures that once required extensive invasive surgery are performed today less evasively by inserting surgical or diagnostic devices through arteries or veins (i.e., vascular procedures, such as vascular catheterizations). These procedures are much safer and require significantly less recovery time than more evasive procedures performed years earlier before vascular techniques were developed. To prevent clots from forming in the vessels after surgery, the patient may require anticoagulation medications, which often results in excessive bleeding. To stop bleeding after vascular procedures, most clinics use pressure applied directly to the wound. This pressure must be held over both the entry point wound in the skin and the wound that was created in the vessel.
Direct pressure can be applied manually by a clinician, but in many instances the pressure is needed for an extended period of time to decrease or stop the bleeding. To save the clinicians time, many types of compression devices have entered the market. Examples of these devices are circumferential wraps designed to apply compression pressure over the wound and or artery, and clamp-like devices to apply the compression force.
Typical arterial pressure where many vascular procedures are performed is generally equal to the patient's blood pressure. This pressure is measured in millimeters of mercury (“mmHg”). 51.7 mmHg is equal to one pound per square inch (“psi”). A blood pressure of 80/120 mmHg is 1.5/2.3 psi. To close an artery by direct pressure compression for a patient with that blood pressure, a compression force or compression pressure of greater than 2.3 psi is all that is needed.
However, too much pressure will occlude the artery/vessel, and too little pressure will result in excessive bleeding or a hematoma. Ideal compression is termed “Patent Hemostasis.” Patent Hemostasis is sufficient pressure to stop bleeding at the skin and artery/vessel, but not so much pressure as to compress the artery/vessel closed.
Teaching a new clinician how much compression force to apply is often difficult. In addition, even if properly calculated and taught, the application of the necessary compression force by many circumferential devices is variable over time. In addition, the patient may often exhibit changes in blood pressure after vascular procedures. A simple device to provide appropriate compression force feedback so as to allow such compression devices to operate properly is needed in the medical industry.
The present invention addresses the long-felt need to accurately measure or observe the compression force applied to an artery so that Patent Hemostasis can be achieved.
This invention relates generally to a device for measuring compression force to achieve hemostasis. The device employs a compressible portion with a rigid or semi-rigid bottom and an indicator of compression force that is visible to the clinician when applying a compression device.
Briefly, the present invention is directed, in an embodiment, to a device for improving hemostasis procedures, by providing the clinician direct feedback to the amount of compression force being applied to a wound site.
In certain embodiments, the indicator device may be a standalone device used in conjunction with adhesive strips, a hemostasis clamp, or a circumferential wrap.
In other embodiments, the indicator device may be mounted on or with a bracelet to operate as a circumferential compression device.
In other embodiments, to prevent the device from being dislodged from the hemostasis site, the indicator device may be held adjacent to the limb by a circumferential wrap and a strapping system used to apply compression force over the wound.
In other embodiments, the indicator device may be incorporated with an inflatable balloon device.
In other embodiments, the indicator device may employ a compressible polymer material, a balloon, a single spring, or two or more springs to create the compressible structure that applies the compression force.
Reference now will be made in detail to the embodiments of the invention, one or more examples of which are set forth below. Each example is provided by way of explanation of the invention, not a limitation of the invention. In fact, it will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the scope or spirit of the invention. For instance, features illustrated or described as part of one embodiment, can be used on another embodiment to yield a still further embodiment. The following embodiments and aspects thereof are described and illustrated in conjunction with systems, tools and methods which are meant to be exemplary and illustrative and not limiting in scope. In various embodiments one or more of the above-described problems have been reduced or eliminated while other embodiments are directed to other improvements.
Thus, it is intended that the present invention covers such modifications and variations as come within the scope of the appended claims and their equivalents. Other objects, features and aspects of the present invention are disclosed in or are obvious from the following detailed description. It is to be understood by one of ordinary skill in the art that the present discussion is a description of exemplary embodiments only, and is not intended as limiting the broader aspects of the present invention.
It should be understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included within the spirit and purview of this application and the scope of the appended claims. In addition, any elements or limitations of any invention or embodiment thereof disclosed herein can be combined with any and/or all other elements or limitations (individually or in any combination) or any other invention or embodiment thereof disclosed herein, and all such combinations are contemplated with the scope of the invention without limitation thereto.
As shown in
Compression must be held in place to simultaneously control bleeding at the dermatotomy (skin wound) 22 and the arteriotomy (wound in the artery or vessel) 24. The ideal pressure is Patent Hemostasis pressure, which is sufficient pressure to obtain hemostasis at the arteriotomy, but still allow some blood flow through the artery or vein 30. Patent Hemostasis pressure is thought to be approximately mean arterial pressure or “MAP”.
The indicator device of the present invention is designed such that a vertical change in the device provides a horizontal indication of compression force.
The top and bottom of indicator device 10 may be made of any material, including polymeric material, as known in the art, provided it has sufficient rigidity to maintain compression when compression force is applied to the wound sites.
A marked scale 17, as shown in
It may be that that the compression plates (bottom 13 and top 15) do not create sufficient vertical movement to use a direct measurement system. In that case, a movement magnifying system, such as shown in
The device may be of any shape designed to fit the site on the patient where hemostasis is needed.
The device may use a metal spring or multiple springs as the compressible material between the rigid/semi-rigid top 15 and bottom 13. It may also employ an air bladder, a foam, or silicone as the compressible material. Any compressible material may be used provided it is consistent and can be calibrated to provide usable feedback to the clinician. The bladder may be semi-rigid and prefilled with a compressible liquid (air or gas) or the bladder may be designed to expand. The bladder may also be designed to be inflated with a syringe.
Typically, a direct measurement of mass (lbs, kg, etc) is not sufficient and a clinician will want mmHg to coincide with blood pressure. Therefore, the surface area of the foot or skin contact portion of the device must be considered for the tick marks or measurements. It would be possible to create multiple housings that use the same compression indicator device. The compression force markings would be on the housing, with the indicator on the insert.
The main advantage of this design is that the vertical movement is translated to a horizontal movement of the indicator by use of a compressible, flexible material. A pure vertical movement indicator would create a profile that is too high and result in dislodgement by patients. The compression needs to be maintained directly over the dermatotomy and arteriotomy. This unique product creates a sleek design and functional product.
A 3D printer was employed to create a prototype of the present inventive device.
For this example, the compression indicator was used beneath a clear wrap (3 wraps were needed) to simulate hemostasis post radial artery access. As the device was compressed the indicator tape lengthened. In this example, 1.95 lbs of pressure was applied over 1 square inch, so approximately 100 mmHg was applied to the simulated wound site. This amount of compression would create patent hemostasis for most patients. Without the inventive indicator, it would be impossible to know how much compression is being applied.
These and other modifications and variations to the present invention may be practiced by those of ordinary skill in the art, without departing from the spirit and scope of the present invention, which is more particularly set forth in the appended claims. In addition, it should be understood that aspects of the various embodiments may be interchanged in whole or in part. Furthermore, those of ordinary skill in the art will appreciate that the foregoing description is by way of example only, and is not intended to limit the invention so further described in such appended claims. Therefore, the spirit and scope of the appended claims should not be limited to the description of the versions contained therein.
The present application claims the benefit of U.S. Provisional Patent Application No. 63/287,867, filed on Dec. 9, 2021, the entire disclosure of which is incorporated by reference herein.
Number | Date | Country | |
---|---|---|---|
63287867 | Dec 2021 | US |